This Article Full Text Full Text (PDF) All Versions of this Article: 1055-9965.EPI-07-0764v1 17/2/300    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jacobs, E. T. Articles by Thompson, P. A. Search for Related Content PubMed PubMed Citation Articles by Jacobs, E. T. Articles by Thompson, P. A.

Plasma Insulin-Like Growth Factor I Is Inversely Associated with Colorectal Adenoma Recurrence: A Novel Hypothesis

¹ Arizona Cancer Center, ² Mel and Enid Zuckerman Arizona College of Public Health, ³ College of Medicine, and ⁴ Department of Pathology, University of Arizona, Tucson, Arizona and ⁵ Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Requests for reprints: Elizabeth T. Jacobs, Mel and Enid Zuckerman College of Public Health Arizona Cancer Center, University of Arizona P.O. Box 245024, Tucson, AZ 85724-5024. Phone: 520-626-0341; Fax: 520-626-9275. E-mail: jacobse{at}u.arizona.edu

The insulin-like growth factor I (IGF-I) axis has been proposed to be a significant factor in the development of certain cancers, including colorectal. However, results from epidemiologic studies suggest modest effects on colorectal cancer risk. Using cross-sectional and prospective study designs within the same cohort of men who had at least one adenoma at baseline, we investigated whether plasma IGF-I, IGF-I binding protein 1, and IGF-I binding protein 3 were associated with colorectal adenoma characteristics at baseline and whether their levels were related to odds for adenoma recurrence. Plasma levels of each marker were measured at baseline in 299 male participants in the Wheat Bran Fiber Trial, who were followed prospectively for recurrence of their adenomatous lesions. In cross-sectional analyses, plasma IGF-I was significantly positively associated with the presence of adenomas with any villous features (P = 0.04). In contrast, IGF-I levels were inversely associated with odds of colorectal adenoma recurrence, with adjusted odds ratios (95% confidence interval) of 0.55 (0.29-1.01) and 0.49 (0.26-0.91) for the second and third tertiles of IGF-I, respectively, compared with the first tertile (P_trend = 0.02). The inverse association was stronger for advanced adenoma recurrence (P_trend = 0.02) than for nonadvanced recurrence (P_trend = 0.10). These results suggest that, once an adenoma is removed, higher IGF-I levels reduce the odds of the formation of new lesions in the colorectum. (Cancer Epidemiol Biomarkers Prev 2008;17(2):300–5)

This article has been cited by other articles:

				E. L. Ashbeck, E. T. Jacobs, M. E. Martinez, E. W. Gerner, P. Lance, and P. A. Thompson Components of Metabolic Syndrome and Metachronous Colorectal Neoplasia Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1134 - 1143. [Abstract] [Full Text] [PDF]

				S. Khoury-Shakour, S. B. Gruber, F. Lejbkowicz, H. S. Rennert, L. Raskin, M. Pinchev, and G. Rennert Recreational Physical Activity Modifies the Association Between a Common GH1 Polymorphism and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3314 - 3318. [Abstract] [Full Text] [PDF]

				A. Flood, V. Mai, R. Pfeiffer, L. Kahle, C. J. Rosen, E. Lanza, and A. Schatzkin Serum Concentrations of Insulin-Like Growth Factor and Insulin-Like Growth Factor Binding Protein 3 and Recurrent Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1493 - 1498. [Abstract] [Full Text] [PDF]